Lofters, W S <br/><br/>
Phase III double-blind comparison of dolasetron mesylate and ondansetron and an evaluation of the additive role of dexamethasone in the prevention of acute and delayed nausea and vomiting due to moderately emetogenic chemotherapy.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Aug 1997 
 - 2966-73 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1997.15.8.2966  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Antiemetics--adverse effects<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Dexamethasone--administration & dosage<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Indoles--adverse effects<br/>Injections, Intravenous<br/>Male<br/>Middle Aged<br/>Nausea--chemically induced<br/>Ondansetron--adverse effects<br/>Premedication<br/>Quality of Life<br/>Quinolizines--adverse effects<br/>Vomiting--chemically induced